24.05.2016 17:20:11
|
DGAP-Vorabbekanntmachung: B.R.A.I.N. Biotechnology Research and Information Network AG
DGAP-AFR: B.R.A.I.N. Biotechnology Research And Information Network AG: Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]
Report: Annual financial report Date of disclosure / German: December 20, 2016 Date of disclosure / English: December 20, 2016 German: https://www.brain-biotech.de/investor-relations/finanzpublikationen/ English: https://www.brain-biotech.de/en/investor-relations/financial-publications
Report: Annual financial report of the group Date of disclosure / German: December 20, 2016 Date of disclosure / English: December 20, 2016 German: https://www.brain-biotech.de/investor-relations/finanzpublikationen/ English: https://www.brain-biotech.de/en/investor-relations/financial-publications
Report: Financial report of the group (half-year/Q2) Date of disclosure / German: May 31, 2016 Date of disclosure / English: May 31, 2016 German: https://www.brain-biotech.de/investor-relations/finanzpublikationen/ English: https://www.brain-biotech.de/en/investor-relations/financial-publications
24.05.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: B.R.A.I.N. Biotechnology Research And Information Network AG Darmstädter Straße 34-36 64673 Zwingenberg Germany Internet: www.brain-biotech.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
B.R.A.I.N. Biotechnology Research And Information Network AG / Preliminary announcement on the disclosure of financial statements
24.05.2016 17:20
Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act], transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
B.R.A.I.N. Biotechnology Research And Information Network AG hereby
announces that the following financial reports shall be disclosed :
Report: Annual financial report Date of disclosure / German: December 20, 2016 Date of disclosure / English: December 20, 2016 German: https://www.brain-biotech.de/investor-relations/finanzpublikationen/ English: https://www.brain-biotech.de/en/investor-relations/financial-publications
Report: Annual financial report of the group Date of disclosure / German: December 20, 2016 Date of disclosure / English: December 20, 2016 German: https://www.brain-biotech.de/investor-relations/finanzpublikationen/ English: https://www.brain-biotech.de/en/investor-relations/financial-publications
Report: Financial report of the group (half-year/Q2) Date of disclosure / German: May 31, 2016 Date of disclosure / English: May 31, 2016 German: https://www.brain-biotech.de/investor-relations/finanzpublikationen/ English: https://www.brain-biotech.de/en/investor-relations/financial-publications
24.05.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: B.R.A.I.N. Biotechnology Research And Information Network AG Darmstädter Straße 34-36 64673 Zwingenberg Germany Internet: www.brain-biotech.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BRAIN Biotech AGmehr Nachrichten
Analysen zu BRAIN Biotech AGmehr Analysen
Aktien in diesem Artikel
BRAIN Biotech AG | 2,57 | 2,80% |
|